| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $43.8M | +34.9% |
| SG&A Expense | $12.2M | +30.1% |
| Operating Income | -$56.0M | -33.8% |
| Income Tax | $0 | — |
| Net Income | -$51.8M | -26.1% |
| EPS (Basic) | -$1.01 | +55.3% |
| EPS (Diluted) | -$1.01 | +56.5% |
| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.0M | -89.3% |
| Short-term Investments | $85.9M | — |
| Current Assets | $104.9M | -31.0% |
| Total Assets | $123.7M | -18.8% |
| Current Liabilities | $5.2M | +111.2% |
| Total Liabilities | $7.5M | +156.0% |
| Stockholders' Equity | $116.2M | -22.3% |
| Line Item | 2023-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$44.5M | -12.3% |
| Capital Expenditures | $153K | — |
| Investing Cash Flow | -$101.5M | — |
| Financing Cash Flow | $11.6M | -92.2% |
| Free Cash Flow | -$44.6M | — |